S2R overexpression is associated with various forms of cancer as well as both neuropsychiatric disorders (e.g., schizophrenia) and neurodegenerative diseases (Alzheimer’s disease: AD). Here, TMEM97 is linked to early-onset autosomal dominant Alzheimer disease.